BIX 01294
- Product Name
- BIX 01294
- CAS No.
- 1392399-03-9
- Chemical Name
- BIX 01294
- Synonyms
- CS-1418;BIX 01204;BIX01294 HCl;BIX01294 triHCl;BIX 01294 USP/EP/BP;BIX01294 hydrochloride;BIX01294 3hydrochloride;Trihydrochloride Hydrate;BIX 01294 Trihydrochloride Hydrate;BIX01294 hydrochloride BIX-01294 HCL
- CBNumber
- CB92677401
- Molecular Formula
- C28H41Cl3N6O2
- Formula Weight
- 600.02314
- MOL File
- 1392399-03-9.mol
BIX 01294 Property
- storage temp.
- Inert atmosphere,2-8°C
- solubility
- H2O: >20mg/mL
- form
- powder
- color
- white
Safety
- WGK Germany
- 3
- HS Code
- 2933.99.8290
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- B9311
- Product name
- BIX 01294 trihydrochloride hydrate
- Purity
- ≥98% (HPLC), powder
- Packaging
- 5 mg
- Price
- $227
- Updated
- 2025/07/31
- Product number
- B9311
- Product name
- BIX 01294 trihydrochloride hydrate
- Purity
- ≥98% (HPLC), powder
- Packaging
- 25 mg
- Price
- $630
- Updated
- 2025/07/31
- Product number
- B9311
- Product name
- BIX 01294 trihydrochloride hydrate
- Purity
- ≥98% (HPLC), powder
- Packaging
- 5mg
- Price
- $221
- Updated
- 2024/03/01
- Product number
- B9311
- Product name
- BIX 01294 trihydrochloride hydrate
- Purity
- ≥98% (HPLC), powder
- Packaging
- 25mg
- Price
- $525
- Updated
- 2024/03/01
- Product number
- B4211
- Product name
- BIX 01294 Trihydrochloride Hydrate
- Purity
- >85.0%(N)
- Packaging
- 25mg
- Price
- $608
- Updated
- 2024/03/01
BIX 01294 Chemical Properties,Usage,Production
Uses
BIX 01294 trihydrochloride hydrate has been used:
- as a histone methylation inhibitor to treat E4 cells for analysing green fluorescent protein (d2EGFP) expression
- to investigate the role of G9a in neuroblastoma tumor growth
- as specific inhibitor of G9a to treat the SK-N-AS, BE(2)-C, SK-N-DZ, SK-N-F1, and SHEP1 neuroblastoma cell lines
General Description
BIX-01294, a diazepin-quinazolinamine derivative, is a histone-lysine methyltransferase (HMTase) inhibitor that modulates the epigenetic status of chromatin. BIX-01294 inhibits the G9aHMTase dependent levels of histone-3 lysine (9) methylation (H3K9me). Bix-01294 and valproic acid, a histone deacetylase (HDAC) inhibitor, may replace the requirement for ectopic OCT4 (POU5F1) and cMyc respectively in pluripotent stem cell induction (iPS) recipes.
Biochem/physiol Actions
BIX 01294 is a selective histone methyl transferase inhibitor. In its inhibition of the histone lysine methyltransferases, BIX 01294 does not compete with cofactor S-adenosyl-methionine. The target enzyme is G9a, and it selectively impairs G9a HMTase and the generation of H3K9me2 in vitro.
in vivo
BIX-01294 trihydrochloride (10 mg/kg; IP; three times a week for 2 weeks) significantly reduces tumor growth and tumor burden in recurrent tumor cells. Primary tumor growth is not inhibited[1].
| Animal Model: | Female MMTV-rtTA;TetO-Her2/neu (MTB;TAN) and TetO-Her2/neu (TAN) mice with recurrent or primary tumor cells[1] |
| Dosage: | 10 mg/kg |
| Administration: | IP; three times a week for 2 weeks |
| Result: | Significantly reduced tumor growth and tumor burden in recurrent tumor cells. Primary tumor growth was not inhibited. Slowed the growth of orthotopic recurrent tumors in athymic nude recipients. |
storage
room temperature (desiccate)
BIX 01294 Preparation Products And Raw materials
Raw materials
Preparation Products
BIX 01294 Suppliers
- Tel
- --
- Fax
- --
- customerservice@tocris.co.uk
- Country
- United Kingdom
- ProdList
- 5726
- Advantage
- 77